We were delighted to discuss with Vasileios Kouranos (Royal Brompton Hospital, London, UK) the current unmet need in the treatment of pulmonary and cardiac sarcoidosis alongside the therapeutic advances being made.
Questions
- Could you give us a brief overview of pulmonary and cardiac sarcoidosis, their prevalence and prognosis? (0:22)
- What are the major unmet needs in the diagnosis and treatment of pulmonary and cardiac sarcoidosis? (1:33)
- Could you tell us a little about the utility of cardiac magnetic resonance imaging (MRI) and other imaging techniques for the screening of cardiac sarcoidosis? (2:20)
- Could you tell us a little about the latest advances in the treatment of pulmonary and cardiac sarcoidosis? (3:07)
- What further studies are needed to optimise screening and treatment strategies? (4:05)
- Could you tell us a little more about these steroid-sparing treatments? (04:58)
Speaker disclosure: Vasileios Kouranos has nothing to disclose in relation to this interview.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress 2020.
